Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience

بواسطة Schrama, J G, Holtkamp, M J, Baars, J W, Schornagel, J H, Rodenhuis, S
منشور في 2003

Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses

بواسطة Sneeuw, K C A, Aaronson, N K, Sprangers, M A G, Detmar, S B, Wever, L D V, Schornagel, J H
منشور في 1999

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.

بواسطة van der Wall, E., Rutgers, E. J., Holtkamp, M. J., Baars, J. W., Schornagel, J. H., Peterse, J. L., Beijnen, J. H., Rodenhuis, S.
منشور في 1996

Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients

بواسطة Joerger, M, Huitema, A D R, van den Bongard, H J G D, Baas, P, Schornagel, J H, Schellens, J H M, Beijnen, J H
منشور في 2006

Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer

بواسطة Helgason, H H, Kruijtzer, C M F, Huitema, A D R, Marcus, S G, ten Bokkel Huinink, W W, Schot, M E, Schornagel, J H, Beijnen, J H, Schellens, J H M
منشور في 2006